Development of novel fluorinated reagents for preparation of drugs.
(FLUNOVELTY)
Start date: Nov 1, 2015,
End date: Oct 31, 2016
PROJECT
FINISHED
Around 20% of all modern drugs are fluorinated organic molecules. During the recent years, however, pharmaceutical companies struggle to deliver novel drugs to the market, because of the lack of innovative practical reagents and reactions towards “drug-like” compounds. In this project, we will address this issue by discovering novel small fluorinating reagents - fluorinated diazoalkanes, - elaborate their practical reactions, and use this knowledge to develop alternative synthetic approaches to some known drugs (AS-136A, Celecoxib).
Get Access to the 1st Network for European Cooperation
Log In
or
Create an account
to see this content
Coordinator
- RUE VAUQUELIN 10 75231 PARIS (France)
Details
- 100% € 92 538,00
-
H2020-EU.1.3.2.
- Project on CORDIS Platform